Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123246) titled 'Morphometric Analysis of Meibomian Glands and Levator Palpebrae Superioris in Thyroid Eye Disease with Upper Eyelid Retraction: An AI-Driven Quantitative Approach' on April 23.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Eye Hospital, Wenzhou Medical University
Condition:
Thyroid eye disease upper eyelid retraction
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-25
Target Sample Size: NA:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317849
Disclaimer: Curated by HT Syndication....